Family Medicine Doctors in Middleton, MA Accepting Medicare
5 Family Medicine doctors found. Showing 1 - 5
 Meghan L. Tramontozzi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 South Main Street, Middleton, MA 01949 Phone: 978-774-2555 Fax: 978-774-8715 |
Erin Kelleher, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 |
 Mark E Allara, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 Fax: 978-774-8715 |
Dana D. Mann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 Fax: 978-887-8715 |
Dr. Michael Yoon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 147 S Main St, Middleton, MA 01949 Phone: 978-774-2555 Fax: 978-774-8715 |
News Archive
Diets high in sodium could be a novel risk factor in development of multiple sclerosis
Here's another reason to put the salt shaker down: New research in mice shows that diets high in sodium may be a novel risk factor in the development of multiple sclerosis (MS) by influencing immune cells that cause the disease. Although this research does implicate salt intake as a risk factor, it is important to note that dietary salt is likely just one of the many environmental factors contributing to this complex disease, and very much influenced by one's genetic background.
CytoDyn submits PRO 140 Phase 2b trial protocol to FDA for treatment substitution in HIV patients
CytoDyn Inc., a biotechnology company focused on the development of new therapies for combating infection with immune deficiency viruses, announced today that the Company has submitted a Phase 2b clinical trial protocol, for its lead product candidate, PRO 140, to the U.S. Food and Drug Administration for treatment substitution in patients with Human Immunodeficiency Virus (HIV).
UC San Francisco researchers outline cell-based therapeutics as a "third pillar" of medicine
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals, according to UC San Francisco researchers.
FDA clears rapid test for the detection of influenza A/H5N1
The U.S. Food and Drug Administration today cleared for marketing a new, more rapid test for the detection of influenza A/H5N1, a disease-causing subtype of the avian influenza A virus that can infect humans.
› Verified 1 days ago